A novel approach to the management of pregnancies complicated by uteroplacental insufficiency and previous stillbirth

Australian and New Zealand Journal of Obstetrics and Gynaecology

Volumn 38, Issue 4, 1998, Pages 391-395

  Oyelese, K O ^a   Black, R S ^a   Lees, C C ^a,b   Campbell, S ^a  

^a ST GEORGE'S UNIVERSITY OF LONDON   (United Kingdom)

^b KING S COLLEGE HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; GLYCERYL TRINITRATE;

ADULT; ARTERIAL CIRCULATION; ARTICLE; CASE REPORT; CLINICAL FEATURE; DOPPLER FLOWMETRY; FEMALE; FETUS ECHOGRAPHY; FOLLOW UP; HUMAN; INTRAUTERINE GROWTH RETARDATION; ORAL DRUG ADMINISTRATION; PLACENTA INSUFFICIENCY; PREECLAMPSIA; PRIORITY JOURNAL; STILLBIRTH; TRANSDERMAL DRUG ADMINISTRATION; UTERINE ARTERY; VENOUS CIRCULATION;

EID: 0031797945     PISSN: 00048666     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1479-828X.1998.tb03094.x     Document Type: Article

References (15)

1. Campbell S, Diaz Recasens J. Griffin D et al. New Doppler technique for assessing uteroplacental blood flow. Lancet 1983; 1: 675-677.
2. Harrington K, Cooper D, Lees C, Hecher K, Campbell S. Doppler ultrasound of the uterine arteries: the importance ot bilateral notching in the prediction of preeclampsia, placental abruption or delivery of a small-for-gestational-age baby Ultrasound Obstet Gynecol 1996; 7: 182-188.
3. CLASP (Collaborative Low-dose Aspirin Study in Pregnancy) Collaborative Group. CLASP: a randomised trial of low-dose aspirin for the prevention and treatment of preeclampsia among 9364 pregnant women. Lancet 1994; 343(8898):619-629.
4. Wallenburg HCS, Dekker GA, Makovitz JW, Rotmans P. Low dose aspirin prevents pregnancy-induced hypertension and preeclampsia in angiotensin-sensitive primigravidae. Lancet 1986: I: 1-3
5. Schiff E, Peleg E, Goldenberg M et al. The use of aspirin to prevent pregnancy induced hypertension and ratio of thromboxane A2 to prostacyclin in relatively high risk pregnancies. N Engl J Med 1989; 321: 351-356.
6. Beaufils M, Uzan S, Donsimoni R, Colau JC. Prevention of preeclampsia by early anti-platelet therapy. Lancet 1985; 1: 840-842.
7. Bower S, Harrington K, Schuchter K, McGirr C, Campbell S. Prediction of preeclampsia by abnormal uterine artery Doppler ultrasound and modification by aspirin. Br J Obstet Gynaecol 1996; 103: 625-629.
8. Lees C, Valensise H, Black R et al. A randomized double blind placebo controlled trial of transdermal glyceryl trinitrate in the prophylaxis of preeclampsia and its complications. Ultrasound Obstet Gynecol (in press).
9. CLASP collaborative group. Low dose aspirin in pregnancy and early childhood development: follow up of the collaborative low dose aspirin study in pregnancy. Br J Obstet Gynaecol 1995; 102: :861-868.
10. Morris NH, Eaton BM, Dekker G. Nitric oxide, the endothelium, pregnancy and preeclampsia. Br J Obstet Gynaecol 1996; 103: 4-15.
11. Ramsay B, De Belder A, Campbell S, Moncada S, Martin JF. A nitric oxide donor improves uterine artery diastolic blood flow in normal early pregnancy and in women at high risk of preeclampsia. Eur J Clin Invest 1994; 24:76-78.
12. Grunewald C, Kublickas M, Carlstrom K, Lunell N-O, Nisell H. Effects of nitroglycerin on the uterine and umbilical circulation in severe preeclampsia Obstet Gynecol 1995; 86. 600-604.
13. Lees C, Langford E, Brown AS et al. The effects of S-nitrosoglutathione on platelet activation, hypertension and uterine and fetal Doppler in severe preeclampsia. Obstet Gynecol 1996; 88:14-19.
14. Radomski MW, Palmer RM. Moncada S. The anti-aggregating properties of vascular endothelium: interactions between prostacyclin and nitric oxide. Br J Pharmacol 1987; 92: 639-646.
15. Morrison JJ, Rennie JM. Clinical, scientific and ethical aspects of fetal and neonatal care at extremely preterm periods of gestation. Br J Obstet Gynaecol 1997; 104: 1341-1350.